Effects of alimentary lipemia and inflammation on platelet CD40-ligand

Thrombosis Research

Volumn 120, Issue 5, 2007, Pages 703-708

  Kälsch, Thorsten ^a   Elmas, Elif ^a   Nguyen, Xuan Duc ^b   Kralev, Stefan ^a   Leweling, Hans ^a   Klüter, Harald ^b   Dempfle, Carl Erik ^a   Borggrefe, Martin ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Alimentary lipemia; Atherosclerosis; Inflammation; Platelet CD40L

Indexed keywords

CD40 ANTIGEN; CD40 LIGAND; LIPOPOLYSACCHARIDE; PADGEM PROTEIN; THROMBOPLASTIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; BLOOD SAMPLING; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN EXPERIMENT; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; INFLAMMATION; LIPID DIET; MALE; MONOCYTE; NORMAL HUMAN; POSTPRANDIAL STATE; PRIORITY JOURNAL; PROTEIN EXPRESSION; THROMBOCYTE AGGREGATION; TRIACYLGLYCEROL BLOOD LEVEL; UPREGULATION;

ADULT; AGED; ANTIGENS, CD40; BLOOD PLATELETS; CD40 LIGAND; FEMALE; GENE EXPRESSION REGULATION; HUMANS; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIAS; INFLAMMATION; L-SELECTIN; LIPOPOLYSACCHARIDES; MALE; MIDDLE AGED; POSTPRANDIAL PERIOD; THROMBOPLASTIN;

EID: 34547966921     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2006.12.022     Document Type: Article

References (37)

1. Berk B.C., Weintraub W.S., and Alexander R.W. Elevation of C-reactive protein in "active" coronary artery disease. Am J Cardiol 65 (1990) 168-172
2. Buchner K., Henn V., Grafe M., de Boer O.J., Becker A.E., and Kroczek R.A. CD40 ligand is selectively expressed on CD4+ T cells and platelets: implication for CD40-CD40L signalling in atherosclerosis. J Pathol 201 (2003) 288-295
3. Buffon A., Biasucci L.M., Liuzzo G., D'Onofrio G., Crea F., and Maseri A. Widespread coronary inflammation in unstable angina. N Engl J Med 347 (2002) 5-12
4. Cipollone F., Fazia M., Iezzi A., Pini B., Cuccurullo C., Zucchelli M., et al. Blockade of the Angiotensin II type 1 receptor stabilizes atherosclerotic plaques in humans by inhibiting prostaglandin E2-dependent matrix metalloproteinase activity. Circulation 109 (2004) 1482-1488
5. Danesh J., Whincup P., Walker M., Lennon L., Thomson A., Appleby P., et al. Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. BMJ 321 (2000) 199-204
6. Libby P. Inflammation in atherosclerosis. Nature 420 (2002) 868-874
7. Libby P., Ridker P.M., and Maseri A. Inflammation and atherosclerosis. Circulation 105 (2002) 1135-1143
8. Paoletti R., Gotto A.M., and DP.H. Inflammation in atherosclerosis and implications for therapy. Circulation 109 (2004) III-20-III-26
9. Ridker P.M., Cushman M., Stampfer M.J., Tracy R.P., and CH.H. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 336 (1997) 973-979
10. Ridker P.M., Hennekens C.H., Buring J.E., and N.R. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in woman. N Engl J Med 342 (2000) 836-843
11. Torzewski M., Rist C., Mortensen R.F., Zwaka T.P., Bienek M., Waltenberger J., et al. C-reactive protein in the arterial intima: role of C-reactive protein receptor-dependent monocyte recruitment in atherogenesis. Arterioscler Thromb 20 (2000) 2094-2099
12. Willerson J.T., and PM.R. Inflammation as a cardiovascular risk factor. Circulation 109 (2004) II-2-II-10
13. Zwaka T.P., Hombach V., and Torzewski J. C-reactive protein-mediated low density lipoprotein uptake by macrophages: implications for atherosclerosis. Circulation 103 (2001) 1194-1197
14. Zouridakis E., Avanzas P., Arroyo-Espliguero R., Fredericks S., and JC.K. Markers of inflammation and rapid coronary artery disease progression in patients with stable angina pectoris. Circulation 110 (2004) 1747-1753
15. Fichtlscherer S., Breuer S., Heeschen C., Dimmeler S., and Zeiher A.M. Interleukin-10 serum levels and systemic endothelial vasoreactivity in patients with coronary artery disease. Am Coll Cardiol 44 (2004) 44-49
16. Fichtlscherer S., Rosenberger G., Walter D.H., Breuer S., Dimmeler S., and Zeiher A.M. Elevated C-reactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease. Circulation 102 (2000) 1000-1006
17. Freedman J.E. CD40-CD40L and platelet function: beyond hemostasis. Circ Res 92 (2003) 944-946
18. Garlichs C.D., John S., Schmeisser A., Eskafi S., Stumpf C., Karl M., et al. Upregulation of CD40 and CD40 ligand (CD154) in patients with moderate hypercholesterolemia. Circulation 104 (2001) 2395-2400
19. Garlichs C.D., E.S., Raaz D., Schmidt A., Ludwig J., Herrmann M., et al. Patients with acute coronary syndromes express enhanced CD40 ligand/CD154 on platelets. Heart 86 (2001) 649-655
20. Heeschen C., Dimmeler S., Hamm C.W., van den Brand M.J., Boersma E., Zeiher A.M., et al. Soluble CD40 ligand in acute coronary syndromes. N Engl J Med 348 (2003) 1104-1111
21. Henn V., Slupsky J.R., Grafe M., Anagnostopoulos I., Forster R., Muller-Berghaus G., et al. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 391 (1998) 591-594
22. Mach F., Schonbeck U., Sukhova G.K., Atkinson E., and Libby P. Reduction of atherosclerosis in mice by inhibition of CD40 signalling. Nature 394 (1998) 200-2003
23. May A.E., Kälsch T., Massberg S., Herouy Y., Schmidt R., and Gawaz M. Engagement of glycoprotein IIb/IIIa ({alpha}IIb{beta}3) on platelets upregulates CD40L and triggers CD40L-dependent matrix degradation by endothelial cells. Circulation 106 (2002) 2111-2117
24. Schonbeck U., Sukhova G.K., Shimizu K., Mach F., and Libby P. Inhibition of CD40 signaling limits evolution of established atherosclerosis in mice. Proc Natl Acad Sci U S A 97 (2000) 7458-7463
25. Varo N., de Lemos J.A., Libby P., Morrow D.A., Murphy S.A., Nuzzo R., et al. Soluble CD40L: risk prediction after acute coronary syndromes. Circulation 108 (2003) 1049-1052
26. Sanguigni V., Pignatelli P., Lenti L., Ferro D., Bellia A., Carnevale R., et al. Short-term treatment with atorvastatin reduces platelet CD40 ligand and thrombin generation in hypercholesterolemic patients. Circulation 111 (2005) 412-419
27. Hyson D.A., Paglieroni T.G., Wun T., and JC.R. Postprandial lipemia is associated with platelet and monocyte activation and increased monocyte cytokine expression in normolipemic men. Clin Appl Thromb Haemost 8 (2002) 147-155
28. Fuhrman B., Brook J.G., and M.A. Increased platelet aggregation during alimentary hyperlipemia in normal and hypertriglyceridemic subjects. Ann Nutr Metab 30 (1986) 250-260
29. Freese R., and M.M. Postprandial changes in platelet function and coagulation factors after high-fat meals with different fatty acid components. Eur J Clin Nutr 49 (1995) 658-664
30. Goldstein R.E., Redwood D.R., Rosing D.R., Beiser G.D., and SE.E. Alterations in the circulatory response to exercise following a meal and their relationship to postprandial angina pectoris. Circulation 44 (1971) 90-100
31. Silveira A., Karpe F., Johnsson H., Bauer K.A., and Hamsten A. In vivo demonstration in humans that large postprandial triglycride-rich lipoproteins activate coagulation factor VII through the intrinsic coagulation pathway. Arterioscler Thromb Vasc Biol 16 (1996) 1333-1339
32. Zhou L., Xu N., and Nilsson A. Association of prothrombin and protein S with plasma triglyceride-rich lipoproteins in humans after test meals rich in milk fat or soybean oil. Thromb Res 108 (2002) 209-213
33. Tholstrup T., Miller G.J., Bysted A., and Sandstrom B. Effect of individual dietary fatty acids on postprandial activation of blood coagulation factor VII and fibrinolysis in healthy young men. Am J Clin Nutr 77 (2003) 1125-1132
34. Elmas E., Kälsch T., Suvajac N., Leweling H., Neumaier M., Dempfle C.E., et al. Activation of coagulation during alimentary lipemia under real-life conditions. Int J Cardiol 114 2 (2007) 172-175
35. Broijersen A., Karpe F., Hamsten A., Goodall A.H., and Hjemdahl P. Alimentary lipemia enhances the membrane expression of platelet P-selectin without affecting other markers of platelet activation. Atherosclerosis 137 (1998) 107-113
36. Kapur R., Hoffmann C.J., Bhushan V., and MB.H. Postprandial elevation of activated factor VII in young adults. Arterioscler Thromb Vasc Biol 16 (1996) 1327-1332
37. Otterdal K., Pedersen T.M., and Solum N.O. Release of soluble CD40 ligand after platelet activation. Studies on the solubilization phase. Thromb Res 114 (2004) 167-177